System and method for providing light therapy and modifying circadian rhythm

Patent metadata

Field	Value
Publication number	US-2016158486-A1
Application number	US-201414906276-A
Country	US
Kind code	A1
Filing date	Jul 8, 2014
Priority date	Jul 25, 2013
Publication date	Jun 9, 2016
Grant date	—

Abstract

Systems and methods to provide light therapy to a subject use one or more light sources configured to emit electromagnetic radiation in multiple stages using multiple wavelengths. By virtue of the emitted electromagnetic radiation impinging on the subject, the phase of the circadian rhythm of the subject is modified.

First claim

1 . A system to provide light therapy to a subject, the system comprising:
a light source configured to emit electromagnetic radiation, wherein the emitted electromagnetic radiation includes electromagnetic radiation having a variable intensity; one or more processors configured to execute computer program modules, the computer program modules comprising:
a therapy module configured to obtain a light therapy regimen for the subject, wherein the light therapy regimen defines stages including a first stage and a second stage, wherein the first stage is associated with a first period during one or more days, wherein the second stage is associated with a second period during the one or more days that is different from the first period, wherein the light therapy regimen is configured such that:
during the first stage the subject receives pulsed electromagnetic radiation including electromagnetic radiation having a first range of wavelengths, the electromagnetic radiation during pulses being at a first intensity, the first range of wavelengths and the first intensity being selected to stimulate S-cone receptors of the subject upon impingement upon a closed eyelid of the subject, wherein the pulsed electromagnetic radiation received during the first period has a pulse duration up to about 10 minutes and an inter-pulse duration between about 0.1 seconds and about 10 minutes, and
during the second stage the subject receives electromagnetic radiation, wherein one or more parameters of the electromagnetic radiation during the second stage are changed from the pulsed electromagnetic radiation during the first stage such that light therapy provided during the first stage is different from light therapy provided during the second stage; and
a light control module configured to control emission from the one or more light sources in accordance with the light therapy regimen.

2 . The system of claim 1 , wherein the pulsed electromagnetic radiation during the first stage is in a predetermined range of wavelengths, wherein the predetermined range of wavelengths ranges between about 410 nm and about 510 nm.

3 . The system of claim 1 , wherein the light therapy regimen is designed to treat Delayed Sleep Phase Syndrome (DSPS) by modifying a phase of the circadian rhythm of the subject.

4 . The system of claim 1 , wherein the light therapy regimen is designed to treat Advanced Sleep Phase Syndrome (ASPS) by modifying a phase of the circadian rhythm of the subject.

5 . The system of claim 1 , wherein the received electromagnetic radiation during the second stage has a second range of wavelengths ranging between about 590 nm and 700 nm such that cortisol-production by the subject is stimulated without suppressing melatonin-production.

6 . The system of claim 1 , wherein the received electromagnetic radiation during the second stage has a second range of wavelengths ranging between about 500 nm and 530 nm such that a phase of the circadian rhythm of the subject is modified.

7 . The system of claim 1 , wherein the received electromagnetic radiation during the second stage stimulates cortisol-production by the subject and suppresses melatonin-production.

8 - 14 . (canceled)

15 . A system configured to provide light therapy to a
subject having a circadian rhythm, the system comprising: means for obtaining a light therapy regimen for the subject, wherein the light therapy regimen defines stages including a first stage and a second stage, wherein the first stage is associated with a first period during one or more days, wherein the second stage is associated with a second period during the one or more days that is different from the first period, wherein the light therapy regimen includes electromagnetic radiation impinging on a closed eyelid of the subject to provide light therapy for the subject;
means for emitting, during the first stage, pulsed electromagnetic radiation including electromagnetic radiation having a first range of wavelengths, the electromagnetic radiation during pulses being at a first intensity, the first range of wavelengths and the first intensity being selected to stimulate S-cone receptors of the subject upon impingement, wherein the pulsed electromagnetic radiation emitted during the first period has a pulse duration up to about 10 minutes and an inter-pulse duration between about 0.1 seconds and about 10 minutes; and
means for emitting, during the second stage, electromagnetic radiation, wherein one or more parameters of the electromagnetic radiation during the second stage are changed from the pulsed electromagnetic radiation during the first stage such that light therapy provided during the first stage is different from light therapy provided during the second stage.

16 . The system of claim 15 , wherein the light therapy regimen is designed to treat Delayed Sleep Phase Syndrome (DSPS) by modifying a phase of the circadian rhythm of the subject.

17 . The system of claim 15 , wherein the light therapy regimen is designed to treat Advanced Sleep Phase Syndrome (ASPS) by modifying a phase of the circadian rhythm of the subject.

18 . The system of claim 15 , wherein the electromagnetic radiation emitted during the second stage has a second range of wavelengths ranging between about 590 nm and 700 nm such that cortisol-production by the subject is stimulated without suppressing melatonin-production.

19 . The system of claim 15 , wherein the electromagnetic radiation emitted during the second stage has a second range of wavelengths ranging between about 500 nm and 530 nm such that a phase of the circadian rhythm of the subject is modified.

20 . The system of claim 15 , wherein the electromagnetic radiation emitted during the second stage stimulates cortisol-production by the subject and suppresses melatonin-production.

21 . The system of claim 1 , further comprising an eyelid detector, configured and arranged to alter one or more parameters of the electromagnetic radiation in response to a determination that the subject's eyelid is open.

22 . The system of claim 8 , further comprising eyelid detection means, configured and arranged to alter one or more parameters of the electromagnetic radiation in response to a determination that the subject's eyelid is open.

Assignees

• Koninkl Philips Nv

Inventors

• Colbaugh Michael Edward
• Lucci Christopher Scott

Classifications

• A61N2005/0626

  Monitoring, verifying, controlling systems and methods · CPC title

• A61N2005/0663

  Coloured light · CPC title

• A61N2005/0651

  Diodes · CPC title

• A61N2005/0648

  the light being directed to the eyes · CPC title

• A61M21/00 Primary

  Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis · CPC title